A prospective real-world study of efgartigimod in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy

20260 citationsJournal Articlegold Open Access

Authors

Xiangtao Nie · The Affiliated Yongchuan Hospital of Chongqing Medical University

Gen Huang · People's Hospital of Bishan District

Yongbo Ma · Hanzhong Central Hospital

Geke Zhu · The Affiliated Yongchuan Hospital of Chongqing Medical University

Wenjing Qi · The Affiliated Yongchuan Hospital of Chongqing Medical University

Han Zhou · The Affiliated Yongchuan Hospital of Chongqing Medical University

Abstract

This study demonstrates the short-term efficacy and safety of efgartigimod in treating CIDP, suggesting its potential as a safe and effective alternative therapy. Further exploration is needed to determine its suitability for long-term maintenance treatment of CIDP.

Topics & Keywords

Peripheral Neuropathies and Disorders Multiple Sclerosis Research Studies Myasthenia Gravis and Thymoma

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Frontiers in Immunology

Volume 17, pp. 1779544-1779544

DOI: 10.3389/fimmu.2026.1779544

Field-Weighted Citation Impact: 0.00